ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $81,000 | -13.8% | 1,312 | +1.1% | 0.00% | 0.0% |
| Q3 2019 | $94,000 | -19.7% | 1,298 | -9.0% | 0.00% | 0.0% |
| Q2 2019 | $117,000 | -5.6% | 1,427 | -19.2% | 0.00% | 0.0% |
| Q1 2019 | $124,000 | +29.2% | 1,765 | -17.1% | 0.00% | 0.0% |
| Q4 2018 | $96,000 | -28.4% | 2,129 | -10.2% | 0.00% | 0.0% |
| Q3 2018 | $134,000 | +42.6% | 2,372 | +68.6% | 0.00% | 0.0% |
| Q2 2018 | $94,000 | +13.3% | 1,407 | -0.8% | 0.00% | 0.0% |
| Q1 2018 | $83,000 | -28.4% | 1,418 | -21.2% | 0.00% | -50.0% |
| Q4 2017 | $116,000 | +19.6% | 1,799 | -3.5% | 0.00% | 0.0% |
| Q3 2017 | $97,000 | +19.8% | 1,865 | +6.6% | 0.00% | +100.0% |
| Q2 2017 | $81,000 | +14.1% | 1,750 | +21.0% | 0.00% | 0.0% |
| Q1 2017 | $71,000 | 0.0% | 1,446 | +22.3% | 0.00% | -50.0% |
| Q4 2016 | $71,000 | -13.4% | 1,182 | -3.4% | 0.00% | 0.0% |
| Q3 2016 | $82,000 | +925.0% | 1,224 | +716.0% | 0.00% | – |
| Q2 2016 | $8,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |